Cite
MLA Citation
B Glintborg et al.. “FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 553–554. http://access.bl.uk/ark:/81055/vdc_100135153959.0x000061